迪苏尔菲拉姆:一种用于癌症治疗的新型重用药物
Min Zeng1, Baibei Wu2, Wenjie Wei3
1Department of Biochemistry and Molecular Biology, School of Basic Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.
Chinese medical journal
|January 26, 2024
概括
迪苏尔菲拉姆和铜 (DSF/Cu) 显示出作为重用抗癌药物的前景. 这种组合针对包括质母细胞瘤在内的各种癌症,并通过抑制关键癌症通路来克服耐药性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 药物重用 药物重用
背景情况:
- 癌症仍然是一个重大的全球健康挑战,需要创新的治疗策略.
- 药物重新定位为开发新的癌症治疗方法提供了一种具有成本效益和效率的方法.
- 迪苏尔菲拉姆 (DSF) 是美国食品和药物管理局批准的酒药物,显示其作为抗癌剂的潜力.
研究的目的:
- 审查迪苏尔菲拉姆和铜 (DSF/Cu) 的抗瘤机制.
- 突出DSF/Cu对各种癌症的疗效及其向癌症干细胞的能力.
- 探索DSF/Cu在克服化疗耐药性和放射性耐药性的潜力.
主要方法:
- 文献综述总结了DSF/Cu. 的临床前和临床研究.
- 分析分子机制,包括ROS诱导,细胞死亡途径,蛋白酶体抑制和NF-κB信号传递.
- 对DSF/Cu对癌症干细胞和耐药性标记物的影响的评估.
主要成果:
- DSF/Cu在多种癌症类型中表现出抗瘤作用,包括质母细胞瘤,乳腺癌,肝癌,胰腺癌和黑色素瘤.
- 机制包括诱导活性氧物种 (ROS),激活细胞死亡途径,抑制蛋白酶体活性和抑制NF-κB信号传递.
- DSF/Cu有效地向癌症干细胞 (CSC) 和与耐药性相关的分子点.
结论:
- DSF/Cu代表了对各种恶性瘤的有希望的重用治疗策略.
- 它向CSC和克服耐药性的能力为预防瘤复发和转移提供了新的途径.
- 为了改善癌症治疗应用,需要对DSF/Cu进行进一步的临床研究.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
203
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
203
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K


